[Repositioning HCV immunoblot as a targeted confirmatory tool in screening strategies].

Screening for hepatitis C virus (HCV) infection relies on detecting total anti-HCV antibodies through an enzyme-linked immunosorbent assay (ELISA) performed on a single serum sample. However, in population with low seroprevalence, this one-step appro…

Preview only. Read the full abstract at the source